::::: Welcome to PowerPak C.E. (R) :::::

FACULTY

Linda R. Bernstein, Pharm.D.

Clinical Professor

School of Pharmacy

University of California

San Francisco, CA

President

Vita Media Corporation

San Francisco, CA

FINANCIAL DISCLOSURE

Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Linda R. Bernstein reports no arrangement or affiliation with commercial corporations whose products may be mentioned in this program.

ACCREDITATION STATEMENTS

Pharmacists
Jobson is accredited by the Accreditation Council for Pharmacy
Education as a provider of continuing pharmacy education.
Program No.: 430-809-05-094-H01
Credits: 2.0 hours (.20 ceu)

Physicians, Nurse Practitioners, Physician Assistants

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Jobson. PIM is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Postgraduate Institute for Medicine designated this educational activity for a maximum of 1.5 category 1 credits toward the AMA Physician Recognition Award and AANP. Each Physician should claim only those credits that he/she actually spent in the activity.

Nurses

Nursing Continuing Education

CNA/ANCC

This educational activity for 1.7 contact hours is provided by Postgraduate Institute for Medicine (PIM). PIM is an approved provider of continuing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

California Board of Registered Nursing

Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485 for 1.7 contact hours.

Exam processing inquiries and booklet orders to:
CE Customer Service Manager (800) 825-4696
Direct educational content inquiries to:
CE Director (800) 331-9396

TARGET AUDIENCE

This activity has been designed to meet the educational needs of physicians, nurse practitioners, physician assistants, pharmacists and nurses involved in smoking cessation therapy. Estimated time to complete this activity is 1.5 to 2.0 hours.

PURPOSE STATEMENT

The purpose of this program is to provide up-to-date information on smoking cessation therapy to clinicians in order to minimize the health damage of tobacco addiction.

PROGRAM OVERVIEW

This program is intended to educate clinicians about the clinical decision-making tools to optimize success of smoking cessation therapy.

EDUCATIONAL OBJECTIVES

At the conclusion of this lesson, the pharmacist, nurse, and physician should be able to:

State the latest prevalence trends of adult and teenage smoking in the United States,
Explain the toxic actions and health complication of tobacco use with emphasis on nicotine's addictive properties
Describe the latest technologies and delivery forms used in nicotine replacement therapy
Name at least three important conclusions of the 2004 Surgeon General's report on smoking, and
Discuss the pros and cons of each nicotine replacement product.

Disclosure of Unlabeled Use and Disclaimer
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, Power-Pak C.E., and Pfizer. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The author, sponsor, and publisher of this continuing education program have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this monograph have not been evaluated by the Food and Drug Administration. Nutritional products discussed are not intended for the diagnosis, treatment, cure, or prevention of any disease.